-
ASH 2024 | Dr. Zhihui Li: Prognostic Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Advanced Relapsed/Refractory NKTCL Patients
The 66th American Society of Hematology (ASH) Annual Meeting was held from December 7–10, 2024, in San Diego, USA. As one of the largest global academic events in hematology, it showcased cutting-edge research and the latest drug development data. At this prestigious conference, Dr. Zhihui Li from Beijing GoBroad Boren Hospital (Dr. Tong Wu ’s…
-
Advancing Liver Cancer Treatment | Dr. Ming Zhao, Sun Yat-sen University Cancer Center
Dr. Ming Zhao shares key insights on combining local and systemic therapies to improve liver cancer treatment outcomes. Learn how innovative approaches like immunotherapy and targeted treatments are transforming patient care.
-
ESMO Asia 2024 | Dr. Jae-Lyun Lee ： Advances in the Management of Advanced Renal Cell Carcinoma
Urology Frontier: What is the role of multidisciplinary team evaluations for patients with advanced RCC? Dr. Jae-Lyun Lee:At my institution in South Korea, we have a dedicated multidisciplinary team for…
-
Dr. Rui Xu: New Advances in Surgical Treatment of Breast Cancer and Insights into Integrative Medicine | 2024 Yixian Breast Cancer Conference
The 2024 Yixian Breast Cancer Conference and the 2nd China Young Breast Cancer Consensus Conference, held on December 27–28 in Guangzhou, brought together leading experts in breast disease to discuss the latest advancements in treatment and management. The conference also focused on consensus guidelines for diagnosing and treating young breast cancer patients, aiming to improve…
-
AASLD China Spotlight丨Dr. Xin Zheng and Dr. Jia Liu’s Team Unveils Early Immunological Mechanisms in TMF Treatment for Chronic Hepatitis B
Key Findings from the Study The research, conducted by a team including Dr. Jia Liu, Dr. Shue Xiong, Dr. Hang Jia, and Master’s student Xufeng Quan, involved 37 treatment-naïve CHB…
-
ASH 2024 | Dr. Ruidong Zhang and Dr. Peijing Qi: Analysis of Blinatumomab’s Efficacy and Prospects in Pediatric B-ALL
The 66th Annual Meeting of the American Society of Hematology (ASH) was held from December 7 to 10, 2024, in San Diego, USA. This global event brought together leading experts in hematology to discuss the latest advancements in the field. At the meeting, the team led by Dr. Ruidong Zhang from Beijing Children’s Hospital，Capital Medical…
-
ASH 2024丨Dr. Qingxiao Song’s Team Wins Two ASH Abstract Achievement Awards, Explores New Mechanisms and Therapies for cGVHD
The 66th American Society of Hematology (ASH) Annual Meeting, held in San Diego from December 7–10, 2024, brought together global hematology experts to discuss the latest research advancements. Among the noteworthy contributions, Dr. Qingxiao Song’s team from the Hematology Medical Center of The Second Affiliated Hospital of Army Medical University (Xinqiao Hospital) had three studies…
Connecting Medical Expertise through Media
